NHS Obesity Support Service

From July 2025, Woosehill Medical Centre will be taking part in a new NHS-funded weight management service designed to support patients living with obesity in prescribing tirzepatide (Mounjaro) for the treatment of obesity across Buckinghamshire, Oxfordshire, and Berkshire West (BOB ICB).

Who is this service for?

This service is for adults living with obesity who also have certain health conditions and must meet all the requirements.

• Body Mass Index (BMI)
  • BMI of 40 or more, or
  • BMI of 35 or more with health conditions (see below)

Lower BMI thresholds apply for some ethnic groups (South Asian, Black, Middle Eastern, etc.), usually reduced by 2.5 BMI points.

• At least 4 of the 5 following health conditions and criteria should be met:
  • Type 2 diabetes
  • High blood pressure (requiring treatment)
  • High cholesterol or triglycerides (treated with medication) – Must be on a lipid-lowering therapy and the latest Cholesterol (LDL) should be 4.1 or higher, or triglycerides of 1.7 or higher in the past 12 months.
  • Obstructive sleep apnoea (diagnosed)
  • Heart or vascular disease (e.g. heart attack, stroke, peripheral artery disease, heart failure)

Additional Notes:

• Blood test results for cholesterol/triglycerides must be from the last 12 months.
• Patients must be willing to attend regular reviews and commit to a behavioural support programme.
• Patients must not already be on a similar NHS treatment unless transferring with approval.

What do you need to do?

If you are eligible under the above criteria provided to us by the BOB ICB, we will contact you to offer you the opportunity. Even if you think you may be eligible, we won’t be able to offer it to you, as we can’t offer it to you if you don’t meet the above criteria.